Med-Chemist : "Quintessential Medicinal Chemistry"
Showing posts with label
3
.
Show all posts
Showing posts with label
3
.
Show all posts
Thursday, July 23, 2015
Effimune obtains regulatory approval for Phase I clinical trial in humans of its new immunomodulator FR104
›
Effimune announced today that it had received the authorization from the Belgian regulatory authority, the FAMHP (Federal Agency for ...
Friday, December 28, 2012
Dantrolene shows promise for treating DMD
›
We know that, Dantrolene sodium is a muscle relaxant that acts by abolishing excitation-contraction coupling in muscle ...
›
Home
View web version
